MRI and MRI-directed biopsies for the diagnosis of prostate cancer

Mark Emberton

The utilization of MRI for the diagnosis of prostate cancer in men at risk is relatively new. In this interview, filmed at the 2018 Genitourinary Cancers Symposium, in San Francisco, CA, Mark Emberton, MD, FRCS, of University College London, London, UK, explains why the use of MRI is important for the diagnosis and treatment of prostate cancer. Prof. Emberton also explains the problems that can arise from not determining tumor location and volume at diagnosis.

Share this video  
Similar topics
Related videos
2:16
Challenges for prostate cancer: overdiagnosis and unnecessary treatment
Mark Emberton
2:37
Anti-HER2 strategies in breast cancer: the ALTTO trial
Matteo Lambertini
1:48
What do clinicians look for in a surgical robot?
Peter Albers
3:33
Nurse-led rapid access lung cancer clinic in Wales: a case study
Sarah Morgan
1:11
Will diffusion-weighted MRI replace PET-CT in lung cancer?
Katsuo Usuda
Genitourinary Cancer, Prostate Cancer
GU Cancers 2018
Interview
8th February 2018
More from Mark Emberton
Is delayed diagnosis in the UK to blame for poorer cancer outcomes?
Challenges for prostate cancer: overdiagnosis and unnecessary treatment
Does MRI has the ability to transform how prostate cancer is seen and managed?
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJOncology is intended for healthcare professionals